Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.74
-1.67 (-10.84%)
At close: Mar 5, 2026, 4:00 PM EST
13.64
-0.10 (-0.73%)
After-hours: Mar 5, 2026, 4:25 PM EST
Enanta Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Enanta Pharmaceuticals stock have an average target of 20.4, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 48.47% from the current stock price of 13.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Enanta Pharmaceuticals stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 4 | 4 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +45.56% | Feb 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +45.56% | Jan 9, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $17 | Buy | Initiates | $17 | +23.73% | Nov 14, 2025 |
| WestPark Capital | WestPark Capital | Strong Buy Maintains $24 → $28 | Strong Buy | Maintains | $24 → $28 | +103.78% | Sep 30, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $20 → $12 | Buy | Maintains | $20 → $12 | -12.66% | Sep 15, 2025 |
Financial Forecast
Revenue This Year
69.19M
from 65.32M
Increased by 5.91%
Revenue Next Year
65.97M
from 69.19M
Decreased by -4.65%
EPS This Year
-2.42
from -3.84
EPS Next Year
-2.13
from -2.42
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 78.1M | 79.7M | |||
| Avg | 69.2M | 66.0M | |||
| Low | 59.3M | 52.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.6% | 15.2% | |||
| Avg | 5.9% | -4.6% | |||
| Low | -9.1% | -24.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.76 | -1.59 | |||
| Avg | -2.42 | -2.13 | |||
| Low | -3.09 | -2.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.